Homocysteine and atherothrombosis
Authors:
Abstract
Atherosclerosis with or without thrombosis superimposed is the most frequent cause of ischemic heart disease (IHD), peripheral arterial disease, and a main cause of stroke. Conflicting results have been reported in genetic, observational, and experimental studies on the relationship between homocysteine and these atherothrombotic diseases. Although cardiovascular complications are common in homocystinuric pateints (severe hyperhomocysteinemia), IHD, the most frequent manifestation of atherothrombosis in the general population, appears to be rare. On the basis of findings in individuals with hyperhomocysteinemia of genetic origin, there is in fact no clear evidence for a causal role of homocysteine in the pathogenesis of atherothrombotic disease, and the positive association between plasma homocysteine and II ID observed in many, but not all epidemiologic studies does not prove causality. To infer causality from observational studies, there should be a temporal, consistent, strong, independent, graded (dose‐response effect), and duration‐dependent relationship between exposure and outcomes, and a biologically plausible mechanism should exist. The relationship between plasma homocysteine levels and IHD does not fulfill these criteria beyond reasonable doubt. In the general population, plasma homocysteine levels are to a great extent determined by dietary habits, and plasma homocysteine could be a marker, or a consequence, of atherothrombosis and/or risk‐associated behavior (e.g., a diet low in fruits and vegetables) rather than a cause of atherothrombosis. Experimentally, hyperhomocysteinemia is not in itself atherogenic in normal animals with relatively low plasma cholesterol levels. The homocysteine theory of atherosclerosis should be tested more thoroughly in hypercholesterolemic animals that develop atherosclerosis spontaneously to determine whether elevated plasma homocysteine levels are harmful under atherogenic conditions. A causal role of homocystein in atherothrombotic disease remains to be established.Keywords
This publication has 87 references indexed in Scilit:
- Vascular Complications of Severe Hyperhomocysteinemia in Patients with Homocystinuria Due to Cystathionine β-Synthase Deficiency: Effects of Homocysteine-Lowering TherapySeminars in Thrombosis and Hemostasis, 2000
- Homocysteine and atherothrombosis—mechanisms for injuryEuropean Heart Journal, 2000
- Future for folates in cardiovascular diseaseEuropean Journal of Clinical Investigation, 1999
- HOMOCYSTEINE METABOLISMAnnual Review of Nutrition, 1999
- Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parentsJACC, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Failure to produce atherosclerosis in Macaca radiata on a high-methionine, high-fat, pyridoxine-deficient dietAtherosclerosis, 1977
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973